183 related articles for article (PubMed ID: 38643245)
1. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
[TBL] [Abstract][Full Text] [Related]
3. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
[TBL] [Abstract][Full Text] [Related]
4. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies.
Oda K; Uto H; Mawatari S; Ido A
Clin J Gastroenterol; 2015 Feb; 8(1):1-9. PubMed ID: 25575848
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.
Bengtsson B; Stål P; Wahlin S; Björkström NK; Hagström H
Liver Int; 2019 Jun; 39(6):1098-1108. PubMed ID: 30829446
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
Pinyopornpanish K; Al-Yaman W; Dasarathy S; Romero-Marrero C; McCullough A
Dig Dis Sci; 2022 Jun; 67(6):2677-2687. PubMed ID: 34027591
[TBL] [Abstract][Full Text] [Related]
8. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
[TBL] [Abstract][Full Text] [Related]
9. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
11. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
12. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
[TBL] [Abstract][Full Text] [Related]
13. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma.
Benhammou JN; Aby ES; Shirvanian G; Manansala K; Hussain SK; Tong MJ
Sci Rep; 2020 Jun; 10(1):9902. PubMed ID: 32555268
[TBL] [Abstract][Full Text] [Related]
14. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Cernea S; Onișor D
World J Gastroenterol; 2023 Jan; 29(2):286-309. PubMed ID: 36687124
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges.
Berkan-Kawińska A; Piekarska A
Curr Med Res Opin; 2020 Feb; 36(2):235-243. PubMed ID: 31631714
[No Abstract] [Full Text] [Related]
16. Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.
David D; Raghavendran A; Goel A; Bharath Kumar C; Kodiatte TA; Burad D; Abraham P; Ramakrishna B; Joseph P; Ramachandran J; Eapen CE
Indian J Gastroenterol; 2017 Sep; 36(5):373-379. PubMed ID: 28975595
[TBL] [Abstract][Full Text] [Related]
17. Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.
Davitkov P; Hoffman K; Falck-Ytter Y; Wilson B; Stojadinovikj G; Anthony DD; Cohen SM; Cooper G
PLoS One; 2023; 18(1):e0280647. PubMed ID: 36693057
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
Tsai PC; Kuo HT; Hung CH; Tseng KC; Lai HC; Peng CY; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Tai CM; Lin CW; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Yeh ML; Huang CF; Hsieh MH; Huang JF; Dai CY; Chung WL; Chen CY; Yu ML;
J Hepatol; 2023 Feb; 78(2):281-292. PubMed ID: 36208843
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
